Longitudinal trajectories of urinary albumin-to-creatinine ratio and risk of proteinuria among Chinese patients with type 2 diabetes: a single−center retrospective cohort study - Report - MDSpire

Longitudinal trajectories of urinary albumin-to-creatinine ratio and risk of proteinuria among Chinese patients with type 2 diabetes: a single−center retrospective cohort study

  • By

  • Qian Chen

  • Tieqiao Wang

  • Xiaoqing Tian

  • Qiankai Jin

  • Li Li

  • Yushan Mao

  • Guoqing Huang

  • June 2, 2026

  • 0 min

Share

Clinical Report: Patterns of Urinary Albumin-to-Creatinine Ratio Over Time

Overview

This study identifies distinct urinary albumin-to-creatinine ratio (UACR) trajectories in Chinese individuals with type 2 diabetes and assesses their association with proteinuria risk.

Background

Monitoring urinary albumin-to-creatinine ratio (UACR) is crucial for assessing kidney damage in patients with type 2 diabetes mellitus (T2DM). Diabetic kidney disease (DKD) is a major complication of T2DM, affecting a significant proportion of patients and leading to increased morbidity and mortality.

Data Highlights

UACR TrajectoryProteinuria Risk (HR)95% CI
Mid-range normal48.4014.67-159.67
Rising with fluctuation509.56157.01–1653.70

Key Findings

  • Three distinct UACR trajectories were identified: low-normal, mid-range normal, and rising with fluctuation.
  • Mid-range normal UACR trajectory is associated with a significantly increased proteinuria risk (HR = 48.40).
  • The rising with fluctuation UACR trajectory shows an even higher proteinuria risk (HR = 509.56).
  • Eleven significant features were identified as predictors of UACR trajectories, including baseline UACR and various clinical parameters.
  • Group-based trajectory modeling (GBTM) effectively captures the dynamic changes in UACR over time.

Clinical Implications

The identification of distinct UACR trajectories can inform assessments of proteinuria risk in patients with T2DM.

Conclusion

The study highlights the importance of UACR trajectory patterns in predicting proteinuria risk among individuals with T2DM.

Related Resources & Content

  1. Author(s)/Org, Source, Year -- Title
  2. Author(s)/Org, Source, Year -- Title
  3. Author(s)/Org, Source, Year -- Title
  4. Author(s)/Org, Source, Year -- Title
  5. The Journal of Clinical Endocrinology & Metabolism — Plasma Protein Levels as Indicators of Kidney Function Progression in Individuals with Type 2 Diabetes
  6. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026
  7. Urine Albumin-Creatinine Ratio (uACR) | National Kidney Foundation
  8. Assess Urine Albumin - NIDDK
  9. https://kdigo.org/wp-content/uploads/2026/03/KDIGO-2026-Diabetes-and-CKD-Guideline-Update-Public-Review-Draft-March-2026.pdf
  10. A meta-analysis of albuminuria as a surrogate endpoint for kidney failure | Nature Medicine
  11. Proteinuria or Albuminuria as Markers of Kidney and Cardiovascular Disease Risk: An Individual Patient–Level Meta-analysis - PMC
  12. Clinical Features and Implications of Albuminuria Trajectories in Type 2 Diabetes | Endocrine Society
  13. Variability in the urinary albumin-to-creatinine ratio predicts mortality in patients with type 2 diabetes - ScienceDirect
  14. SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria: A Meta-Analysis - PMC
  15. Effects of Sodium Glucose Cotransporter 2 Inhibitors by Diabetes Status and Level of Albuminuria: A Meta-Analysis - PMC
  16. Efficacy and safety of finerenone in Asian patients with type 2 diabetes and chronic kidney disease: A FIDELITY analysis by baseline kidney function - ScienceDirect
  17. Frontiers | Impact of finerenone on chronic kidney disease progression in Chinese patients with type 2 diabetes: a FIGARO-DKD subgroup analysis

Original Source(s)

Related Content